Pablo Legorreta

Mr. Pablo Legorreta is a Founder & Chief Executive Officer at RP Management LLC.
He has over 20 years of experience investing in pharmaceutical royalties, and building and managing a rapidly growing life sciences investment company that is today one of the largest dedicated life sciences investors in the world.
Prior to founding Royalty Pharma in 1996, Mr. Legorreta was an investment banker at Lazard Frères in Paris and New York.
Mr. Legorreta is also a co-founder of Pharmakon Advisors, a leading provider of debt capital to the life sciences industry.
He has a degree in industrial engineering from Universidad Iberoamericana in Mexico City.
He serves on the Board of Directors of Epizyme (Nasdaq: EPZM) and on the Board of Governors of the New York Academy of Sciences, as well as the Boards of Trustees of Rockefeller University, Brown University, the Hospital for Special Surgery, Pasteur Foundation (the U.S.
affiliate of the French Institute Pasteur), Open Medical Institute and Park Avenue Armory.